Rapamycin: Essential for Organ Transplant Success

P

Peter Attia MD discusses rapamycin's use as an immune suppressant.

Quotes From Source

“FDA approves this drug for organ transplantation...”

Story of claim

Rapamycin, approved by the FDA in 1999, is used as an immune suppressant in organ transplants, preventing rejection and aiding recovery.

  • Goal: Understand rapamycin's clinical use in transplantation.
  • Proof: FDA approval in 1999 validated its effective use in organ transplants.
  • Nuances:
    • Approved by FDA in 1999.
    • Used in heart, kidney, liver transplants.
    • Initially developed for antifungal properties.
  • Impact on Life: Rapamycin aids patients in accepting transplanted organs, significantly improving survival rates.

Investments

  • Price:
  • Time:
  • Effort:

Risks

Requires careful monitoring to avoid immune system suppression.

Get Started 🚀

  • Consult with a transplant specialist.
  • Understand the role of rapamycin in your transplant treatment plan.

Brogevity AI can make mistakes. Check important info.

Reference Video